Role of intracellular redox status in apoptosis induction of human T- cell leukemia virus type I-infected lymphocytes by 13-cis-retinoic acid

Cancer Research

Volumn 57, Issue 21, 1997, Pages 4916-4923

  Furuke, Keizo ^a,b,e   Sasada, Tetsuro ^a   Ueda Taniguchi, Yasuyo ^d   Yamauchi, Akira ^b   Inamoto, Takashi ^c   Yamaoka, Yoshio ^b   Masutani, Hiroshi ^a   Yodoi, Junji ^a,c  

^a Kyoto University   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

^e CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BUTHIONINE SULFOXIMINE; GLUTATHIONE; INTERLEUKIN 2; ISOTRETINOIN; PEROXIDE; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; LYMPHOCYTE; MALIGNANT TRANSFORMATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; T CELL LEUKEMIA; VIRUS INFECTION;

ADULT; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BUTHIONINE SULFOXIMINE; CATALASE; CELL DIVISION; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; ISOTRETINOIN; KERATOLYTIC AGENTS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; LEUKOCYTES, MONONUCLEAR; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0030830915     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Yodoi, J., and Uchiyama, T. Human T-cell leukemia virus type 1 (HTLV-1)-associated diseases; virus, IL-2 receptor dysregulation, and redox regulation. Immunol. Today, 13: 405-410, 1992.
2. Taniguchi, Y. U., Furuke, K., Masutani, H., Nakamura, H., and Yodoi, J. Cell cycle inhibition of HTLV-1-transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors. Oncol. Res., 7: 183-189, 1995.
3. Roberts, A. B., and Sporn, M. B. Cellular biology and biochemistry of the retinoids. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, Vol. 2, pp. 209-. Orlando, FL: Academic Press, Inc., 1984.
4. Strickland, S., and Mahdavi, V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell, 15: 393-403, 1978.
5. Breitman, T. R., Selonick, S. E., and Collins, S. J. Induction of differentiation of the human premyelocytic leukemia. Proc. Natl. Acad. Sci. USA, 77: 2936-2940, 1980.
6. Petkovich, M., Brand, N. J., Krust, A., and Chambon, P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (Lond.), 330: 444-450, 1987.
7. Giguere, V., Ong, E. S., Segui, P., and Evans, R. M. Identification of a receptor for the morphogen retinoic acid. Nature (Lond.), 330: 624-629, 1987.
8. Mangelsdorf, D. A., Ong, E. S., Duck, J. A., and Evans, R. M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature (Lond.), 345: 224-229, 1990.
9. Oro, A. E., McKeown, M., and Evans, R. M. Relationship between the product of the Drosophila ultraspiracle locus and the vertebrate retinoid X receptor. Nature (Lond.), 347: 298-301, 1990.
10. Giguere, V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoic signaling. Endocr. Rev., 15: 61-79, 1994.
11. Allenby, G., Bocquel, M. T., Saunders, M., Kazmer, S., Speck, J., Rosenberger, M., Lovey, A., Kastner, P., Grippo, J. F., Chanbon, P., and Levin, A. A. Retinoic acid receptors and retinoid X receptors: interaction with endogenous retinoic acids. Proc. Natl. Acad. Sci. USA, 90: 30-34, 1993.
12. Nakamura, H., Matsuda, M., Furuke, K., Kitaoka, Y., Iwata, S., Toda, K., Inamoto, T., Yamaoka, Y., Ozawa, K., and Yodoi, J. Adult T cell leukemia-derived factor/ human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol. Lett., 42: 75-80, 1994.
13. Matsuda, M., Masutani, H., Nakamura, H., Miyajima, S., Yamauchi, A., Yonehara, S., Uchida, A., Irimajiri, K., Horiuchi, A., and Yodoi, J. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J. Immunol., 147: 3837-3841, 1991.
14. Wong, G. H., Elwell, J. H., Oberley, L. W., and Goeddel, D. V. Manganese superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell, 58: 923-931, 1989.
15. Buttke, T. M., and Sandstrom, P. A. Oxidative stress as a mediator of apoptosis. Immunol. Today, 15: 7-10, 1994.
16. Broaddus, V. C, Yang, L., Scavo, L. M., Ernst, J. D., and Boylan, A. M. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J. Clin. Invest., 98: 2050-2059, 1996.
17. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75: 241-251, 1993.
18. Staal, F. J. T., Roederer, M., Herzenberg, L. A., and Herzenberg, L. A. Intracellular thiols regulate activation of nuclear factor kB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA, 87: 9943-9947, 1990.
19. Roederer, M., Ela, S. W., Staal, F. T. J., Herzenberg, L. A., and Herzenberg, L. A. N-acetylcysteine: a new approach to anti-HIV therapy. AIDS Res. Hum. Retroviruses, 8: 209-217, 1992.
20. Kohno, T., Yamada, Y., Hala, T., Mori, H., Yamamura, M., Tomonaga, M., Urata, Y., Goto, S., and Kondo, T. Relation of oxidative stress and glutathione synthesis to CD95 (Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells. J. Immunol., 156: 4722-4728, 1996.
21. Castro, O. S., and Covarrubias, L. Role of retinoic acid and oxidative stress in embryonic stem cell death and neural differentiation. FEBS Lett., 381: 93-97, 1996.
22. Yamauchi, A., Masutani, H., Tagaya, Y., Wakasugi, N., Mitsui, A., Nakamura, H., Inamoto, T., Ozawa, K., and Yodoi, J. Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agent. Mol. Immunol., 29: 263-270, 1992.
23. Duke, R. C., and Cohen, J. I. Morphological and biological assays of apoptosis. In: J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (eds.), Current Protocols in Immunology, . New York: Greene/Wiley-Interscience, 1992.
24. Nicoletti, I., Migliorati, G., Pagliacci, M. C. Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and now cytometry. J. Immunol. Methods. 139: 271-279, 1991.
25. Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M., and Strober W. (eds.), Current Protocols in Immunology, . New York: Greene/Wiley-Interscience, 1992.
26. Ishida, Y., Agata, Y., Shibahara, K., and Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J., 11: 3887-3895, 1992.
27. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
28. McConkey, D. J., Chandra, J., Wright, S., Plunkett, W., McDonnell, T. J., Reed, J. C., and Keating, M. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of Bcl-2 and Bax. J. Immunol., 756: 2624-2630, 1996.
29. Nagata, S., and Goldstein, P. The Fas death factor. Science (Washington DC), 267: 1449-1456, 1995.
30. Buttke, T. M., and Sandstrom, P. A. Redox regulation of programmed cell death in lymphocytes. Free Radical Res., 22: 389-397, 1995.
31. Hiraku, Y., and Kawanishi, S. Oxidative DNA damage and apoptosis induced by benzene metabolites. Cancer Res., 56: 5172-5178, 1996.
32. Sies, H. Oxidative Stress: Oxidants and Antioxidants. San Diego, CA: Academic Press, Inc., 1991.
33. Cotgreave, L. Moldeus, P., and Schuppe, I. The metabolism of N-acetyl-L-cysteine by human endothelial cells. Biochem. Pharmacol., 42: 13-16, 1991.
34. Meister, A. Metabolism and function of glutathione. Trends Biochem. Sci., 6: 231-234, 1981.
35. Martin, S. J., Bradley, J. G., and Cotter, T. G. HL-60 cells induced to differentiate toward neutrophils subsequently die via apoptosis. Clin. Exp. Immunol., 79: 448-453, 1990.
36. Oridate, N., Lotan, D., Mitchell, M. F., Hong, W. K., and Lotan, R. Induction of apoptosis by retinoids in human cervical carcinoma cell lines. Int. J. Oncol., 7: 433-441, 1995.
37. Zhang, L. X., Mills, K. J., Dawson, M. I., Collins, S. J., and Jetten, A. M. Evidence for the involvement of retinoic acid receptor RAR-α-dependent pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J. Biol. Chem., 270: 6022-6029, 1995.
38. Nagy, L., Thomazy, V. A., Shipley, G. L., Fesus, L., Lamph, W., Heyman, R. A., Chandraratna, R. A., and Davies, P. J. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol., 15: 3540-3551, 1995.
39. Clifford, J., Chiba, H., Sobieszczuk, D., Metzger, D., and Chambon, P. RXRα-null F9 embryonal carcinoma cells are resistant to the differentiation, antiproliferative, and apoptotic effects of retinoids. EMBO J., 15: 4142-4155, 1996.
40. Delia, D., Aiello, A., Formelli, F., Fontanella, E., Costa, A., Miyashita, T., Reed, J. C., and Pierotti, M. A. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. Blood, 85: 359-367, 1995.
41. Elstner, E., Linker, I. M., Umiel, T., Le, J., Grillier, I., Said, J., Shintaku, I. P., Krajewski, S., Reed, J. C., Binderup, L., and Koeffler, H. P. Combination of a potent 20-epi-vitamin D, analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res., 56: 3570-3576, 1996.
42. Agarwal, N., and Mehta, K. Possible involvement of Bcl-2 pathway in retinoid X receptor α-induced apoptosis of HL-60 cells. Biochem. Biophys. Res. Commun., 230: 251-253, 1997.
43. Okazawa, H., Shimizu, J., Kamei, M., Imafuku, I., Hamada, H., and Kanazawa, I. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells. J. Cell Biol., 132: 955-968, 1996.
44. Hamilton, T. C., Winker, M. A., Louie, K. G., Batist, G., Behrens, B. C., Tsuruo, T., Grotzinger, K. R., McKoy, W. H., Young, R. C., and Ozols, R. F. Augmentation of Adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian cancer cell lines by buthionine sulfoximine-mediated glutathione depletion. Biochem. Pharmacol., 34: 2583-2586, 1985.
45. Gallo, J. M., Brennan, J., Hamilton, T. C. Halbherr, T., Laub, P. B., Ozols, R. F., and O'Dwyer, P. J. Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO. Cancer Res., 55: 4507-4511, 1995.
46. Sasada, T., Iwata, S., Sato, N., Kitaoka, Y., Hirota, K., Nakamura, K., Nishiyama, A., Taniguchi, Y., Takabayashi, A., and Yodoi, J. Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. J. Clin. Invest., 97: 2268-2276, 1996.
47. 2 for platelet-derived growth factor signal transduction. Science (Washington DC), 270: 296-299, 1995.
48. Schalleuter, K. U. The stereospecific suicide inhibition of human melanoma thioredoxin reductase by 13-cis-retinoic acid. Biochem. Biophys. Res. Commun., 160: 573-579, 1989.
49. Schalleuter, K. U., and Wood, J. M. The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem. Biophys. Res. Commun., 136: 630-637, 1986.
50. Tagaya, Y., Maeda, Y., Mitsui, A., Kondo, N., Mitsui, H., Hamuro, J., Brown, N., Arai, K., Yokota, T., Wakasugi, H., and Yodoi, J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologuous to thioredoxin: possible involvement of dithiolreduction in the IL-2 receptor induction. EMBO J., 8: 757-764, 1989.
51. Vora, M., and Karasek, M. A. Retinoids up-regulate phagocytosis by human dermal microvascular endothelial cells. J. Cell. Physiol., 159: 450-456, 1994.